Therapy for canine idiopathic epilepsy receives FDA conditional approval
The FDA announced it has conditionally approved phenobarbital tablets (Fidoquel-CA1; Genus Lifesciences Inc.) to control seizures that are associated with idiopathic epilepsy in dogs. This product is the only phenobarbital tablets to receive FDA …